Structure Therapeutics Stock Rises After Trial Shows Up to 15.3% Greater Weight Loss
Structure Therapeutics says patients taking its obesity treatment lost as much as 15.3% more body weight than placebo. The CEO called the data a potential 'best-in-class' breakthrough.
Investor's Business Daily
2 min read
Stocks
Biotechnology
Healthcare